Search Results 81-90 of 410 for ★베스트토토안전확인【평생베스트.com】베스트토토검증★

  1. Study of rSIFN-co for Patients with Advanced Solid Tumors - Mayo Clinic

    ... best. Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  2. Study to Assess the Effectiveness and Safety of Bradanicline in Patients with Chronic Cough - Mayo Clinic

    ... best. Study IDs. Site IRB. Rochester, Minnesota: 18-006858. Sponsor Protocol Number: ATA101-PN-001. About this study. The purpose of this study is to evaluate ...

  3. Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery - Mayo Clinic

    PURPOSE: This phase I/II trial studies the side effects and best dose of giving sorafenib tosylate together with hypoxia-activated prodrug TH-302 and to see ...

  4. A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  5. Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant - Mayo Clinic

    Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunosuppressive therapy, such as dexamethasone, may ...

  6. A Study to Evaluate the Effectiveness and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects with Mycosis Fungoides - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  7. Study to Validate Auto Registry and Integration of Ultrasound into Procedure - Mayo Clinic

    ... best. Study IDs. Site IRB. Rochester, Minnesota: 18-005963. Sponsor Protocol Number: 18-005963. About this study. The purpose of this study is to compare the ...

  8. Cardiovascular Outcomes Assessment of the MitraClip Therapy Percutaneous Therapy for High Surgical Risk Patients - Mayo Clinic

    ... best. Study IDs. Site IRB. Rochester, Minnesota: 12-006984. NCT ID: NCT01626079. Sponsor Protocol Number: 11-512. About this study. The purpose of the ...

  9. A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501) - Mayo Clinic

    This trial incorporates both a novel up front GVHD therapy (sirolimus) as well as a novel BMT CTN developed acute GVHD biomarker test. Participation eligibility.

  10. A Study to Evaluate the Combination of Binimetinib and Palbociclib in Treating Patients with KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer - Mayo Clinic

    Binimetinib and palbociclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as TAS- ...